Recent News

• 03.20.2025 - Financial results for the Fourth Quarter 2024 – conference call
• 03.12.2025 - Leerink Global Biopharma Conference 2025
• 03.12.2025 - Leerink Global Biopharma Conference 2025
• 03.06.2025 - Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025
• 03.05.2025 - Autolus Therapeutics to Participate in Upcoming Investor Conferences
• 01.17.2025 - Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings
• 01.13.2025 - Autolus Therapeutics Provides Business Updates and 2025 Overview
• 01.13.2025 - Autolus Therapeutics Provides Business Updates and 2025 Overview
• 12.10.2024 - Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
• 12.02.2024 - Autolus Therapeutics Announces Publication of Data from the FELIX study of obe-cel in r/r Adult B-ALL Patients in The New England Journal of Medicine

Recent Filings

• 01.13.2025 - 8-K Current report
• 01.13.2025 - EX-99.1 EX-99.1
• 11.14.2024 - S-8 Securities to be offered to employees in employee benefit plans
• 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.12.2024 - EX-99.1 EX-99.1